However, ectopically expressed anti-miR-150 and miR-150 in CD4 cells derived from myasthenia gravis patients presented some in-vitro difference in survival with anti-miR-150 but not with miR-150 (43). The gene discussed is CD4; the disease is myasthenia gravis.